1. Andersson, K., Bergstroma, G., Petzold, M., & Carlsten, A. (2007). Impact of a generic substitution reform on patients’ and society’s expenditure for pharmaceuticals. Health Policy, 81, 376–384.
2. Beck, K., Kunze, U., & Oggier, W. (2004). Selbstdispensation: Kosten treibender oder Kosten daempfender Faktor? [Physician dispensing: A cost increasing or cost decreasing factor?]. Managed Care, 6, 5–8.
3. Ben-Akiva, M., & Lerman, S. R. (1985). Discrete choice analysis—Theory and application to travel demand. Cambridge, MA: MIT.
4. Bradley, D., & Lesu, R. (2006). Optimal regulation of health systems with induced demand and ex post moral hazard. Annales D’Economie et de Statistique, 83, 279–293.
5. CMS. (2004). Safe and effective approaches to lowering state prescription drug costs: Best practices among state Medicaid drug programs. Technical report, Centers for Medicare & Medicaid Services.